Peptide Tk-PQ induces immunosuppression in skin allogeneic transplantation via increasing Foxp3+ Treg and impeding nuclear translocation of NF-κB

    loading  Checking for direct PDF access through Ovid


HighlightsTk-PQ showed an immune-suppressive effect without obvious cytotoxicity in a mouse skin allo-transplantation model.Tk-PQ promoted of the type 2 immune response after allo-transplantation.Tk-PQ increased the ratio of Th2 and CD4+CD25+Foxp3+ Treg cells via the PI3K/mTOR pathway in the spleen and peripheral blood.Tk-PQ downregulated pro-inflammatory cytokines and decreased NF-κB activation.Solid organ transplantation is used as the last resort for patients with end-stage disease, but allograft rejection is an unsolved problem. Here, we showed that Tk-PQ, a peptide derived from trichosanthin, had an immune-suppressive effect without obvious cytotoxicity in vitro and in a mouse skin allo-transplantation model. In vitro, treatment of Tk-PQ administrated type 2 T helper cell (Th2)/regulatory T-cell (Treg) cytokines, and increased the ratio of CD4+CD25+Foxp3+ Treg by repressing the PI3K/mTOR pathway. In addition, Tk-PQ decreased NF-κB activation to downregulate pro-inflammatory cytokines. Tk-PQ treatment in the mouse skin transplantation model also caused the similar molecular and cellular phenotypes. Furthermore, Tk-PQ enhanced the suppressive function of Treg by increasing Foxp3 expression, and substantially improved allograft survival. These finding demonstrate that Tk-PQ has the potential to be used in clinical allogeneic transplantation.

    loading  Loading Related Articles